Get the latest Science News and Discoveries

Efficacy of homoharringtonine-based induction regimen in acute myeloid leukemia (AML) with double-mutated CCAAT/enhancer-binding protein alpha (CEBPA): A prospective multicenter, single-arm trial

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of AML

AML

Photo of enhancer

enhancer

Photo of efficacy

efficacy

Related news:

Efficacy of commercial disinfectants Virkon®S and Microchem Plus against poliovirus

Efficacy of commercial disinfectants Virkon®S and Microchem Plus against poliovirus

Mass General Brigham-led trial shows a less-intensive drug combination is more effective in treating AML

« Strength training not linked to heart problems for people with arrhythmogenic cardiomyopathy

Varietal selection in response to climate change: possible solutions could lie in the history of wheat and barley genes »